Avalon Ventures XI, L.P.
10% owner at Janux Therapeutics.
- Rank
- 685th of 813
- Companies held
- 1
- Largest holding
- JANX, 100.0% of total
- Latest SEC filing
- Jun 3, 2024
- Listed but not counted
- $99.0M
What the $79.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Janux Therapeutics JANX Common Stock | Indirectly (see filing footnote) | 4,479,492 | $10.29 | $46.1M | 57.8% | Form 4, Nov 13, 2023 |
| Janux Therapeutics JANX Common Stock | Directly | 3,271,216 | $10.29 | $33.7M | 42.2% | Form 4, Jun 3, 2024 |
Share counts are the amounts Avalon Ventures XI, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Avalon Ventures XI, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Janux Therapeutics JANX Common Stock | Through Avalon BioVentures SPV I, LP Held by a company or fund the insider manages | 4,031,543 | $10.29 | $41.5M | — | Form 4, Feb 29, 2024 |
| Janux Therapeutics JANX Common Stock | Through Avalon BioVentures SPV I, L.P. Held by a company or fund the insider manages | 3,340,018 | $10.29 | $34.4M | — | Form 4, Jun 3, 2024 |
| Janux Therapeutics JANX Common Stock | Through Avalon BioVentures I, LP Held by a company or fund the insider manages | 849,854 | $10.29 | $8.7M | — | Form 4, Nov 13, 2023 |
| Janux Therapeutics JANX Common Stock | Through Avalon BioVentures I, LP Held by a company or fund the insider manages | 764,869 | $10.29 | $7.9M | — | Form 4, Feb 29, 2024 |
| Janux Therapeutics JANX Common Stock | Through Avalon BioVentures I, LP Held by a company or fund the insider manages | 633,673 | $10.29 | $6.5M | — | Form 4, Jun 3, 2024 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 682 | Gigafund 1, LP 10% owner, Angel Studios | $81.8M |
| 683 | Technology Impact Fund, LP 10% owner, Fervo Energy | $80.3M |
| 684 | Infinite Acquisitions Partners LLC 10% owner, Falcon's Beyond Global | $79.9M |
| 685 | Avalon Ventures XI, L.P. 10% owner, Janux Therapeutics | $79.8M |
| 686 | Suvretta Capital Management, LLC Director, Veradermics | $79.6M |
| 687 | Insight Venture Partners X, L.P. 10% owner, Hinge Health | $79.0M |
| 688 | Suntx Capital Partners L P Director, Construction Partners | $78.8M |
Questions
How much stock does Avalon Ventures XI, L.P. own?
Avalon Ventures XI, L.P. holds $79,754,785 in listed stock based on SEC filings and current prices, mostly Janux Therapeutics (JANX). That ranks 685th on the Stock Rich List.
Is this Avalon Ventures XI, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.